Skip to main content
SpringerLink
Log in
Book cover

Textbook of Penile Cancer pp 125–142Cite as

Management of Penile Cancer Using Penile-Preserving Techniques

  • Chapter
  • First Online:

  • 599 Accesses

Abstract

Penile cancer is a rare disease, in the UK it accounts for <1% of all male malignancies. The incidence of penile cancer in England and Wales is 1.2–1.5 per 100,000 per year.1 This figure is very similar to other Western European and North American countries. However, in parts of Africa, Asia, and South America penile cancer has been reported to account for up to 20% of all male malignancies.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   159.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Cancer trends in England and Wales. Available at: www.statistics.gov.uk. 1950–1999.

  2. Pow Sang MR, Benavente V, Pow Sang JE, et al. Cancer of the penis. Cancer Control. 2002;9:305-314.

    PubMed  Google Scholar 

  3. Broders AC. Squamous cell epithelioma of the skin. Ann Surg. 1921;73:141.

    Article  PubMed  CAS  Google Scholar 

  4. National Institute for Clinical Excellence. Guidance on Cancer Services. Improving Outcomes in Urological Cancers-the Manual. London: NICE; 2002:83-85. http://www.nice.org.uk/pdf/Urological_Manual.pdf.

  5. Opjordsmoen S, Fossa SD. Quality of life in patients treated for penile cancer. A follow-up study. Br J Urol. 1994;74(5):652-657.

    Article  PubMed  CAS  Google Scholar 

  6. Rempelakos A, Bastas E, Lymperakis CH, et al. Carcinoma of the penis: experience from 360 cases. J BUON. 2004;9(1):51-55.

    PubMed  CAS  Google Scholar 

  7. Leijte JA, Kirrander P, Antonini N, et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow up based on a two centre analysis of 700 patients. Eur Urol. 2008;54(1):161-168.

    Article  PubMed  Google Scholar 

  8. Ornellas AA, Kinchin EW, Nobrega BL, et al. Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol. 2008;97(6):487-495.

    Article  PubMed  Google Scholar 

  9. Agrawal A, Pai D, et al. The histological extent of the local spread of carcinoma of the penis and its therapeutic implications. BJU Int. 2000;85(2):299-301.

    Article  PubMed  CAS  Google Scholar 

  10. Hoffman M, Renshaw A, Loughlin KR. Squamous cell carcinoma of the penis and microscopic pathologic margins. How much margin is needed for local cure? Cancer. 1999;85(7):1565-1568.

    Article  PubMed  CAS  Google Scholar 

  11. Minhas S, Kayes O, Hegarty P, et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int. 2005;96(7):1040-1043.

    Article  PubMed  Google Scholar 

  12. Tercedor J, Lopez Hernandez B. Papilomavirus humanos y carcinoma epidermoide cutaneo-mucoso. Piel. 1991;6:470-471.

    Google Scholar 

  13. Malek RS. Laser treatment of premalignant and squamous cell lesions of the penis. Lasers Surg Med. 1992;12:246-253.

    Article  PubMed  CAS  Google Scholar 

  14. Goette DK, Elgart M, DeVillez RL. Erythroplasia of Queyrat. Treatment with topically applied fluorouracil. JAMA. 1975;232(9):934-937.

    Article  PubMed  CAS  Google Scholar 

  15. Micali G, Nasca MR, Tedeschi A. Topical treatment of intraepithelial penile carcinoma with imiquimod. Clin Exp Dermatol. 2003;28(suppl 1):4-6.

    Article  PubMed  Google Scholar 

  16. Dawber R, Colver G, Jackson A. Premalignant lesions. In: Dawber R, Colver G, Jackson A, eds. Cutaneous Cryosurgery. London: Martin Dunitz; 1992:77-93.

    Google Scholar 

  17. Varma S, Holt PJA, Anstey AV. Erythroplasia of Queyrat treated with topical aminolaevulinic acid photodynamic therapy: a cautionary tale. Br J Dermatol. 2000;142:825-828.

    Article  PubMed  CAS  Google Scholar 

  18. Stables GI, Stringer MR, Robinson DJ, Ash DV. Erythroplasia of Queyrat treated by topical aminolaevulinic acid photodynamic therapy. Br J Dermatol. 1999;140(3):514-517.

    Article  PubMed  CAS  Google Scholar 

  19. Axcrona K, Brennhovd B, Alfsen GC, Giercksky KE, Warloe T. Photodynamic therapy with methyl aminolevulinate for atypical carcinoma in situ of the penis. Scand J Urol Nephrol. 2007;41(6):507-510.

    Article  PubMed  CAS  Google Scholar 

  20. Windhal T, Hellsten S. Laser treatment of localised squamous cell carcinoma of the penis. J Urol. 1995;154:1020-1023.

    Article  Google Scholar 

  21. Shirahama T, Takemoto M, Nishiyama K, et al. A new treatment for penile conservation in penile carcinoma: a preliminary study of combined laser hyperthermia, radiation and chemotherapy. Br J Urol. 1998;82:687-693.

    PubMed  CAS  Google Scholar 

  22. Meijer RP, Boon TA, van Venrooij GE, Wijburg CJ. Longterm follow-up after laser therapy for penile carcinoma. Urology. 2007;69(4):759-762.

    Article  PubMed  Google Scholar 

  23. Bandieramonte G, Colecchia M, Mariani L, et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report of 224 patients. Eur Urol. 2008;54(4):875-882.

    Article  PubMed  Google Scholar 

  24. Tietjen DN, Malek RS. Laser therapy of squamous cell dysplasia and carcinoma of the penis. Urology. 1998;52(4):559-565.

    Article  PubMed  CAS  Google Scholar 

  25. Windahl T, Anderson SO. Combined laser treatment for penile carcinoma: results after long-term follow up. J Urol. 2003;169(6):2118-2121.

    Article  PubMed  Google Scholar 

  26. Maiche AG, Pyrhonen S. Verrucous carcinoma of the penis: three cases treated with interferon-alpha. Br J Urol. 1997;79:481-483.

    PubMed  CAS  Google Scholar 

  27. Risse L, Negrier P, Dang PM, et al. Treatment of verrucous carcinoma with recombinant alpha-interferon. Dermatology. 1995;190(2):142-144.

    Article  PubMed  CAS  Google Scholar 

  28. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000;86(4):459-465.

    Article  PubMed  CAS  Google Scholar 

  29. Hadway P, Corbishley CM, Watkin NA. Total glans resurfacing for premalignant lesions of the penis: initial outcome data. BJU Int. 2006;98(3):532-536.

    Article  PubMed  Google Scholar 

  30. Bissada NK. Conservative extirpative treatment of cancer of the penis. Urol Clin North Am. 1992;19(2):283-292.

    PubMed  CAS  Google Scholar 

  31. McDougall WS, Kirchner FK, Edward RH, Killian LT. Treatment of carcinoma of the penis: the case of primary lymphadenectomy. J Urol. 1986;136:38-41.

    Google Scholar 

  32. Das S. Penile amputation for the management of primary carcinoma of the penis. Urol Clin North Am. 1992;19(2):277-282.

    PubMed  CAS  Google Scholar 

  33. Pizzocaro G, Piva L, Tana S. Up-to-date management of carcinoma of the penis. Eur Urol. 1997;32:5-15.

    PubMed  CAS  Google Scholar 

  34. Colberg JW, Andriloe GL, et al. Surgical management of penile cancer. In: Vogelzang NJ, Scardino PT, Shipley WU, et al., eds. Comprehensive Textbook of Genitourinary Oncology. Baltimore: Williams and Wilkins; 1999:1103-1109.

    Google Scholar 

  35. Pietrzak P, Corbishley C, Watkin NA. Organ sparing surgery for invasive penile cancer. Early follow up data. BJU Int. 2004;94:1253-1257.

    Article  PubMed  Google Scholar 

  36. Lindegaard JC, Nielsen OS, et al. A retrospective analysis of 82 cases of cancer of the penis. Br J Urol. 1996;77(6):883-890.

    PubMed  CAS  Google Scholar 

  37. Horenblas S, Van Tintern H. Squamous cell carcinoma of the penis. IV. Prognostic factors of survival: analysis of tumour, nodes, and metastatic classification system. J Urol. 1994;151(5):1239-1243.

    PubMed  CAS  Google Scholar 

  38. Lont AP, Gallee MPW, Meinhardt W, van Tintern H, Horenblas S. Penis conserving treatment for T1 and T2 penile carcinoma: clinical implications of a local recurrence. J Urol. 2006;176:575-580.

    Article  PubMed  CAS  Google Scholar 

  39. Mohs FE, Snow SN, Larson PO. Mohs micrographic surgery for penile tumours. Urol Clin North Am. 1992;19(2):291-304.

    PubMed  CAS  Google Scholar 

  40. Shindel AW, Mann MW, Lev RY, et al. Mohs micrographic surgery for penile cancer: management and long-term follow up. J Urol. 2007;178(5):1980-1985.

    Article  PubMed  Google Scholar 

  41. Austoni E, Fenice O, Kartalas Goumas Y, et al. New trends in the surgical treatment of penile carcinoma. Arch Ital Urol Androl. 1996;68(3):163-168.

    PubMed  CAS  Google Scholar 

  42. Scardino E, Villa G, Bonomo G, et al. Magnetic resonance imaging combined with artificial erection for local staging of penile cancer. Urology. 2004;63:1158-1162.

    Article  PubMed  CAS  Google Scholar 

  43. Kochhar R, Taylor B, Sangar V. Imaging in primary penile cancer: current status and future directions. Eur Radiol. 2010;20:36-47. doi:10.1007/s00330-009-1521-4.

    Article  PubMed  Google Scholar 

  44. Algaba F, Arce Y, Lopez-Beltran A, et al. Intraoperative frozen section diagnosis in urological oncology. Eur Urol. 2005;47(2):129-136.

    Article  PubMed  CAS  Google Scholar 

  45. Malone PR, Thomas JS, Blick C. A tie over dressing for graft application in distal penectomy and glans resurfacing: the TODGA technique. BJU Int. 2011;107(5):836-840.

    Google Scholar 

  46. Davis JW, Schellhammer PF, Schlossberg SM. Conservative surgical therapy for penile and urethral carcinoma. Urology. 1999;53:386-392.

    Article  PubMed  CAS  Google Scholar 

  47. Hatzichristou DG, Apostolidis A, Tzortzis V, et al. Glansectomy: an alternative surgical treatment for Buschke-Lowenstein tumours of the penis. Urology. 2001;57:966-969.

    Article  PubMed  CAS  Google Scholar 

  48. Smith Y, Hadway P, Biedrzcki O, Perry MJA, Corbishley C, Watkin NA. Reconstructive surgery for invasive squamous carcinoma of the glans penis. Eur Urol. 2007;52(4):1179-1185.

    Article  PubMed  Google Scholar 

  49. Bissada NK, Yakout HH, Fahmy WE, et al. Multi-institutional long-term experience with conservative surgery for invasive penile carcinoma. J Urol. 2003;169(2):500-502.

    Article  PubMed  Google Scholar 

  50. Brown CT, Minhas S, Ralph DJ. Conservative surgery for penile cancer: subtotal glans excision without grafting. BJU Int. 2005;96:911-912.

    Article  PubMed  Google Scholar 

  51. Smith Y, Hadway P, Ahmed S, et al. Penile preserving surgery for male distal urethral carcinoma. BJU Int. 2007;100(1):82-87.

    Article  PubMed  Google Scholar 

  52. Gulino G, Sasso F, Falabella R, et al. Distal urethral reconstruction of the glans for penile carcinoma: results of a novel technique at 1-year follow up. J Urol. 2007;178(3):941-944.

    Article  PubMed  CAS  Google Scholar 

  53. Miranda-Sousa A, Keating M, Moreira S, Baker M, Carrion R. Concomitant ventral phalloplasty during penile implant surgery: a novel procedure that optimizes patient satisfaction and their perception of phallic length after penile implant surgery. J Sex Med. 2007;4:1494-1499.

    Article  PubMed  Google Scholar 

  54. Shabbir M, Hughes BE, Swallow T, Corbishley C, Perry MJA, Watkin N. Management of chronic ulceration after radiotherapy for penile cancer. J Urol. 2008;179(4):785.

    Google Scholar 

  55. Ozsahin M, Jichlinski P, Weber DC, et al. Treatment of penile carcinoma: To cut or not to cut? Int J Radiat Oncol Biol Phys. 2006;66(3):674-679.

    Article  PubMed  Google Scholar 

  56. Gerbaulet A, Lambin P. Radiation therapy of cancer of the penis. Indications, advantages and pitfalls. Urol Clin North Am. 1992;19(2):325-332.

    PubMed  CAS  Google Scholar 

  57. Akimoto T, Mitsuhashi N, Takahashi I, et al. Brachytherapy for penile cancer using silicon mold. Oncology. 1997;54(1):23-27.

    Article  PubMed  CAS  Google Scholar 

  58. Neave F, Neal AJ, Hoskin PJ, et al. Carcinoma of the penis: a retrospective review of treatment with iridium mould and external beam irradiation. Clin Oncol R Coll Radiol. 1993;5(4):207-210.

    Article  PubMed  CAS  Google Scholar 

  59. Koch MO, Smith JA Jr. Local recurrence of squamous cell carcinoma of the penis. Urol Clin North Am. 1994;21(4):739-743.

    PubMed  CAS  Google Scholar 

  60. Ravi R, Chaturvedi HK, Sastry DVLN. Role of radiation therapy in the treatment of carcinoma of the penis. Br J Urol. 1994;74:646-651.

    Article  PubMed  CAS  Google Scholar 

  61. McLean M, Ahmed M, Warde P, et al. The results of primary radiation therapy in the management of squamous cell carcinoma of the penis. Int J Radiat Oncol Biol Phys. 1993;25(4):623-628.

    Article  PubMed  CAS  Google Scholar 

  62. Horenblas S, van Tinteren H, et al. Squamous cell carcinomas of the penis. II. Treatment of the primary tumour. J Urol. 1992;147:1533-1538.

    PubMed  CAS  Google Scholar 

  63. Shammas FV, Ous S, Fossa SD. Cisplatin and 5-fluorouracil in advanced cancer of the penis. J Urol. 1992;147(3):630-632.

    PubMed  CAS  Google Scholar 

  64. Corral DA, Sella A, Pettaway CA, et al. Combination chemotherapy for metastatic or locally advanced genitourinary squamous cell carcinoma: a phase II study of methotraxate, cisplatin and bleomycin. J Urol. 1998;160(5):1770-1774.

    Article  PubMed  CAS  Google Scholar 

  65. Haas GP, Blumenstein BA, Gangliano RG, et al. Cisplatin, methotraxate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol. 1999;161(6):1823-1825.

    Article  PubMed  CAS  Google Scholar 

  66. Roth AD, Berney CR, Rohner AS, et al. Intra-arterial chemotherapy in locally advanced or recurrent carcinomas of the penis and anal canal: an active treatment modality with curative potential. Br J Cancer. 2000;83(12):1637-1642.

    Article  PubMed  CAS  Google Scholar 

  67. Kattan J, Culine S, Droz JP, et al. Penile cancer chemotherapy: twelve years’ experience at Institut Gustave-Roussy. Urology. 1993;42(5):559-562.

    Article  PubMed  CAS  Google Scholar 

  68. Ahmed T, Sklaroff R, Yagoda A. Sequential trials of methotrexate, cisplatin and bleomycin for penile cancer. J Urol. 1984;132(3):465-468.

    PubMed  CAS  Google Scholar 

  69. Bandieramonte G, Lepera P, Mogha D, Faustini M, Pizzocaro G. Neoadjuvant chemotherapy and conservative surgery for exophytic T1N0 carcinoma of the penis. Fourth International Congress on Anticancer Chemotherapy; 1993; Paris. Abstract 178.

    Google Scholar 

  70. Mitropoulos D, Dimopoulos MA, Kiroudi-Voulgari A, et al. Neoadjuvant cisplatin and interferon-alpha 2B in the treatment and organ preservation of penile carcinomas. J Urol. 1994;152(4):1124-1126.

    PubMed  CAS  Google Scholar 

  71. Cotsadze D, Matveev B, Zak B, Mamaladze V. Is conservative organ-sparing treatment of penile carcinoma justified? Eur Urol. 2000;38:306-312.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Churchill Hospital, Oxford, Oxfordshire, UK

    Paul Hadway M.B.B.S., MRCS., MSc. FRCS (Urol.)

  2. Harold Hopkins Department of Urology, Royal Berkshire Hospital, Reading, Berkshire, UK

    Peter R. Malone M.B.B.S., FRCS, M.S., FEBU

  3. Department of Urology and Andrology, University College London Hospital, London, UK

    Suks Minhas M.D., FRCS (Urol.)

  4. Department of Urology, University College London Hospital, London, UK

    Asif Muneer B.Sc. (Hons.), M.B., Ch.B., FRCS (Eng.), FRCS (Ed.), M.D., FRCS (Urol.)

Authors
  1. Paul Hadway M.B.B.S., MRCS., MSc. FRCS (Urol.)
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter R. Malone M.B.B.S., FRCS, M.S., FEBU
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Suks Minhas M.D., FRCS (Urol.)
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Asif Muneer B.Sc. (Hons.), M.B., Ch.B., FRCS (Eng.), FRCS (Ed.), M.D., FRCS (Urol.)
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Urology, Univeristy College London Hospitals, Euston Road, London, NW1 2PG, United Kingdom

    Asif Muneer

  2. University College London Hospital, Euston Road, London, N1W 2PG, United Kingdom

    Manit Arya

  3. Antoni van Leeuwenhoekhuis, Department of Urology, Netherlands Cancer Institute, Amsterdam, 1066 CX, Netherlands

    Simon Horenblas

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag London Limited

About this chapter

Cite this chapter

Hadway, P., Malone, P.R., Minhas, S., Muneer, A. (2011). Management of Penile Cancer Using Penile-Preserving Techniques. In: Muneer, A., Arya, M., Horenblas, S. (eds) Textbook of Penile Cancer. Springer, London. https://doi.org/10.1007/978-1-84882-879-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84882-879-7_6

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84882-878-0

  • Online ISBN: 978-1-84882-879-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation